These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35455338)

  • 1. Global Pandemic Preparedness: Optimizing Our Capabilities and the Influenza Experience.
    Rockman S; Taylor B; McCauley JW; Barr IG; Longstaff R; Bahra R
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving pandemic preparedness through better, faster influenza vaccines.
    Newland M; Durham D; Asher J; Treanor JJ; Seals J; Donis RO; Johnson RA
    Expert Rev Vaccines; 2021 Mar; 20(3):235-242. PubMed ID: 33576708
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
    ; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
    Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
    Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
    Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness.
    Ruscio B; Bolster A; Bresee J;
    Vaccine; 2020 Apr; 38(16):3179-3183. PubMed ID: 32171576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness.
    Ghiga I; Richardson S; Álvarez AMR; Kato M; Naidoo D; Otsu S; Nguyen PT; Nguyen PN; Nguyen T
    Vaccine; 2021 Jan; 39(2):364-371. PubMed ID: 33293160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic.
    Porter RM; Goldin S; Lafond KE; Hedman L; Ungkuldee M; Kurzum J; Azziz-Baumgartner E; Nannei C; Bresee JS; Moen A
    Vaccine; 2020 Jan; 38(5):1152-1159. PubMed ID: 31839465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006-2016).
    Palkonyay L; Fatima H
    Vaccine; 2016 Oct; 34(45):5414-5419. PubMed ID: 27498212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines.
    Sayedahmed EE; Elkashif A; Alhashimi M; Sambhara S; Mittal SK
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33019589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.
    Singh N; Pandey A; Mittal SK
    Expert Rev Mol Med; 2010 Apr; 12():e14. PubMed ID: 20426889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief.
    Andersen TK; Bodin J; Oftung F; Bogen B; Mjaaland S; Grødeland G
    Front Immunol; 2021; 12():747032. PubMed ID: 34691056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios.
    Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M
    J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?
    Rockman S; Laurie K; Barr I
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32392812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons From Influenza Pandemics of the Last 100 Years.
    Monto AS; Fukuda K
    Clin Infect Dis; 2020 Feb; 70(5):951-957. PubMed ID: 31420670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
    Stavaru C; Onu A; Lupulescu E; Tucureanu C; Rasid O; Vlase E; Coman C; Caras I; Ghiorghisor A; Berbecila L; Tofan V; Bowen RA; Marlenee N; Hartwig A; Bielefeldt-Ohmann H; Baldwin SL; Van Hoeven N; Vedvick TS; Huynh C; O'Hara MK; Noah DL; Fox CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):1009-26. PubMed ID: 26618392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining the approach to vaccines against influenza A viruses with pandemic potential.
    Czako R; Subbarao K
    Future Virol; 2015; 10(9):1033-1047. PubMed ID: 26587050
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.